Author

AV Mitchell

National Institutes of Health

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

CP Jewell· 1 shared Dalen ChaniD· 1 shared HM Wade· 1 shared Lauren M. JenkinsiD· 1 shared Michael M. GottesmaniD· 1 shared N Poungpeth· 1 shared Nisha R. PawariD· 1 shared Pedro J. BatistaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

CP Jewell

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A whole genomic CRISPR-Cas9 screen identifies the amino acid transporter SLC43A1 (LAT3) as a major determinant of oxaliplatin sensitivity in colorectal cancer cells

Nisha R. Pawar, HM Wade, Zoè Jackson, N Poungpeth, AV Mitchell, CP Jewell, Dalen Chan, Robert W. Robey, Pedro J. Batista, Lauren M. Jenkins, Michael M. Gottesman

The paper identifies SLC43A1 (LAT3) as a key determinant of oxaliplatin sensitivity in colorectal cancer cells through CRISPR screens and functional validation.

Molecular Cancer Therapeutics · Jun 2, 2026Peer-reviewedCancer Biology